Medicina
Departamento
Università di Udine
Udine, ItaliaPublicaciones en colaboración con investigadores/as de Università di Udine (26)
2023
-
Characterization and outcomes of 414 patients with primary SS who developed haematological malignancies
Rheumatology (United Kingdom), Vol. 62, Núm. 1, pp. 243-255
-
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG
Critical Care, Vol. 27, Núm. 1
2022
2020
-
Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?
Clinical Microbiology and Infection, Vol. 26, Núm. 8, pp. 1024-1033
-
Association of genomic domains in BRCA1 and BRCA2 with prostate cancer risk and aggressiveness
Cancer Research, Vol. 80, Núm. 3, pp. 624-638
-
Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network
Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1
-
Clinical predictive model of multidrug resistance in neutropenic cancer patients with bloodstream infection due to Pseudomonas aeruginosa
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 4
-
Comparison of the Safety and Tolerance Profile of Micafungin with that of Other Echinocandins and Azoles in Patients with Pre-existing Child–Pugh B or C Liver Disease: A Case–Control Retrospective Study
Infectious Diseases and Therapy, Vol. 9, Núm. 1, pp. 151-163
-
Factors associated with the development of septic shock in patients with candidemia: A post hoc analysis from two prospective cohorts
Critical Care, Vol. 24, Núm. 1
2019
-
Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis
Mycoses, Vol. 62, Núm. 5, pp. 441-449
-
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study
BMJ Open, Vol. 9, Núm. 5
-
Influence of age on the clinical efficacy of tigecycline in severely ill patients
Journal of Global Antimicrobial Resistance, Vol. 18, pp. 199-206
-
Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)
Annals of Oncology, Vol. 30, Núm. 5, pp. 766-773
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study - Authors' response
Journal of Antimicrobial Chemotherapy
-
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
Critical Reviews in Oncology/Hematology, Vol. 134, pp. 39-45
2018
-
Repeated antifungal use audits are essential for selecting the targets for intervention in antifungal stewardship
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 37, Núm. 10, pp. 1993-2000
-
T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: A prospective pilot study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv6-iv12
-
T2MR contributes to the very early diagnosis of complicated candidaemia. A prospective study
Journal of Antimicrobial Chemotherapy, Vol. 73, pp. iv13-iv19
-
Tailoring adjuvant endocrine therapy for premenopausal breast cancer
New England Journal of Medicine, Vol. 379, Núm. 2, pp. 122-137
2017
-
Clinical characteristics and predictors of mortality in cirrhotic patients with candidemia and intra-abdominal candidiasis: a multicenter study
Intensive Care Medicine, Vol. 43, Núm. 4, pp. 509-518